Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Novavax, Inc. - Common Stock (NQ:NVAX)

6.340 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
62 63 Next >
SJM Stock in Focus as J.M. Smucker Anticipates $125 Million Hit From Peanut Butter Recalls
J.M. Smucker (SJM) stock is on the move today after the company revealed the expected impact of its recent peanut butter recalls. 
Via InvestorPlace
NVAX Stock Alert: 14 Things to Know as the Novavax Vaccine Faces the FDA Today
Novavax (NVAX) stock is in the news today as investors prepare for the results from the vaccine company's meeting with the FDA. 
Via InvestorPlace
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga's Premarket Brief On Trending Tickers: Amazon, Alibaba, DiDi, Solaredge, And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. 
Via Benzinga
Avoid Novavax Stock as Its Hopes Dwindle
The FDA approval is the only hope for Novavax. If you own it, hold NVAX stock until the approval but do not take a new position right now. 
Via InvestorPlace
69 Biggest Movers From Friday
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... 
Via Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
These biotech stocks face some key make-or-break events in June that could have big implication for their futures. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mullen (MULN) Stock Shakes Off EV Woes on CEO Interview
Mullen (MULN) stock is bucking the trend of other electric vehicle (EV) companies today with its shares rising higher on an interview. 
Via InvestorPlace
Why Is Lucid Motors (LCID) Stock Down Today?
Lucid Motors (LCID) stock is slipping on Friday but not due to any news directly from the electric vehicle (EV) company. 
Via InvestorPlace
Novavax (NVAX) Stock Falls 25% on FDA Heart Inflammation Warning
Novavax (NVAX) stock is falling on Friday after the FDA requested a heart inflammation warning for the company's Covid-19 vaccine. 
Via InvestorPlace
Novavax Crashes After FDA Suggests Its Covid Vaccine Causes Heart Inflammation
Six recipients of the Covid vaccine experienced myocarditis or pericarditis. 
Via Investor's Business Daily
40 Stocks Moving In Friday's Mid-Day Session
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. 
Via Benzinga
Jim Cramer Shares His Opinion On Roblox, Century Aluminum And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Roblox Corp (NASDAQ: RBLX) as it is not making money. 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... 
Via Benzinga
Let the Market’s Shakeout Finish Before Buying Novavax Stock
Even after the company's first profitable quarter, it's still too early to accumulate NVAX stock as an analyst issues a bearish price target. 
Via InvestorPlace
$100 Invested In Novavax 5 Years Ago Would Be Worth This Much
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 9.78% on an annualized basis producing an average annual return of 19.75%. Currently, Novavax has a market capitalization of... 
Via Benzinga
70 Biggest Movers From Friday
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
Via Benzinga
Why Novavax Shares Are Diving Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 14.20% at $50.14. Stocks have been highly volatile following the Federal Reserve’s recent 50 basis point rate hike, which has weighed on the... 
Via Benzinga
What Are Whales Doing With Novavax
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Novavax Has Limited Pipeline Upside, Says BofA Analyst: What's Next?
Although Novavax, Inc’s (NASDAQ: NVAX) shares have tanked 59% year to date, there is still room for a further decline, according to BofA Securities. The Novavax Analyst: Alec Stranahan initiated... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
Upgrades 
Via Benzinga
7 Growth Stocks to Avoid Until the Market Crashes Again
Not every investment idea offers a compelling discount. These growth stocks aren't what they once were. 
Via InvestorPlace
3 Oversold Biotech Stocks to Buy Now
Looking for oversold biotech stocks? These three have all seen significant drops this year despite promising catalysts for the future. 
Via InvestorPlace
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
Via Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid... 
Via Benzinga
Cboe's Weekly Market Recap: May 2nd To May 6th
Photo by m. on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.